Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

46.76 -0.32 (-0.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
41 42 Next >
News headline image
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite. 
Via Investor's Business Daily
News headline image
(SNY) - Analyzing Sanofi's Short Interest ↗
 
Via Benzinga
News headline image
Could This Medicine Be the Next Winner for Novartis? ↗
The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials. 
Via The Motley Fool
News headline image
FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth ↗
Monday, the FDA approved Pfizer Inc's (NYSE: PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, to prevent the infection in infants from birth... 
Via Benzinga
News headline image
Is Regeneron Pharmaceuticals Still a Top Growth Stock? ↗
The biotech's focus on innovation could be a boon for shareholders. 
Via The Motley Fool
News headline image
2 Top Biotech Stocks to Buy Right Now ↗
These drugmakers are among the most dominant in the world. 
Via The Motley Fool
News headline image
Why Shares of MacroGenics Are Jumping Thursday ↗
The company announced second-quarter earnings. 
Via The Motley Fool
News headline image
Looking Into Sanofi's Recent Short Interest ↗
 
Via Benzinga
News headline image
The Top Healthcare Stocks to Buy With $100 ↗
There's no need to have a fortune to invest in stocks. 
Via The Motley Fool
News headline image
2 Biotech Stocks That Could Make You Richer ↗
Neither is performing particularly well this year compared to the broader market, but don't let that chase you away. 
Via The Motley Fool
News headline image
Amazon's Boon for Diabetes Patients - Streamlining Pharmacy Discounts ↗
Amazon.Com Inc's (NASDAQ: AMZN) online pharmacy launched a new initiativ 
Via Benzinga
News headline image
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab? ↗
Tiziana Life Sciences, Inc. 
Via Benzinga
News headline image
Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon ↗
Tiziana Life Sciences (NASDAQ: TLSA), a clinical-stage biotechnology company focused on developing immunotherapies, will soon announce the 6-month results for patients with non-active Secondary... 
Via Benzinga
News headline image
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Sanofi (SNY) Q2 2023 Earnings Call Transcript ↗
SNY earnings call for the period ending June 30, 2023. 
Via The Motley Fool
News headline image
Sanofi's Earnings Outlook ↗
 
Via Benzinga
News headline image
iPhone US Shipments Take A Hit, Does Social Media Algorithm Impact Political Beliefs? Research Reveals Answer, Disney Joins Netflix To Crack Down Password Sharing In India: Today's Top Stories ↗
Bloomberg 
Via Benzinga
News headline image
Sanofi Reports Lower Q2 Earnings, But Lifts 2023 Outlook On New Drug Launches ↗
Sanofi SA (NASDAQ: SNY) reported a 1% decline in Q2 business operating in 
Via Benzinga
News headline image
US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon ↗
Stocks appear to have shaken off Thursday's negativity and are positioned for a rebound on upbeat earnings. 
Via Benzinga
News headline image
How Is The Market Feeling About Sanofi? ↗
 
Via Benzinga
News headline image
Enphase Energy, Sanofi, Ford And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Earnings Scheduled For July 28, 2023 ↗
Companies Reporting Before The Bell • Sanofi (NASDAQ:SNY) is likely to report quarterly earnings at $1.58 per share on revenue of $11.32 billion. 
Via Benzinga
News headline image
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports ↗
The Medicines and Healthcare Products Regulatory Agency (MHRA), the U.K.'s drug regulatory authority, is reportedly scrutinizing a category of drugs used in diabetes medication and a weight loss... 
Via Benzinga
News headline image
7 Blue-Chip Stocks That Are Screaming Buys Right Now: July 2023 ↗
Even some of the top players of the market don’t get the attention they deserve, making these blue-chip stocks compelling. 
Via InvestorPlace
News headline image
Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications
From Recludix Pharma, Inc.
Via GlobeNewswire
News headline image
NBCUniversal's Peacock Raises Prices First Time Since Launch, Warren Buffett Sells Majority of Activision Blizzard Stake Before Microsoft Deal Approval, Novartis Launches $15B Share Buyback: Today's Top Stories ↗
Wall Street Journal 
Via Benzinga
News headline image
AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants ↗
The FDA approved AstraZeneca Plc (NASDAQ: 
Via Benzinga
News headline image
Phase 1 Results Are "Extraordinary," Says Chairman Of Scientific Advisory Board As Biomedical Company Preps Phase 2 Trial For MS Treatment ↗
Tiziana Life Sciences (NASDAQ: TSLA) has presented data from its clinical trial showing that five of its six patients with an advanced stage of multiple sclerosis (MS) have shown a reduction in... 
Via Benzinga
News headline image
Is Affordable Insulin Available? Survey Reveals Uninsured Americans Paying More Despite Promised Price Reduction ↗
According to a survey conducted by U.S. 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
41 42 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.